

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Daratumumab iyimithi enamandla yomdlavuza esiza amasosha akho omzimba ukulwa ne-multiple myeloma, uhlobo lomdlavuza wegazi. Le therapy eqondiswe ngqo isebenza ngokunamathela kumaprotheni athile kumaseli omdlavuza, iwashiyele ukuthi abhubhiswe yisistimu yakho yokuzivikela yomzimba.
Uma wena noma othile omkhathalelayo enikwe i-daratumumab, cishe unemibuzo eminingi mayelana nokuthi yini ongayilindela. Le mithi imelela intuthuko enkulu ekwelashweni komdlavuza, futhi ukuqonda ukuthi isebenza kanjani kungakusiza uzizwe uqiniseka kakhulu ngohambo lwakho lokunakekelwa.
I-Daratumumab uhlobo lwe-immunotherapy olubizwa ngokuthi i-monoclonal antibody elapha imidlavuza ethile yegazi. Cabanga ngayo njengomhloli oqeqeshwe kakhulu othola amaseli omdlavuza afihleke emzimbeni wakho futhi athumele amasosha akho omzimba ukuthi awahlole.
Umuthi unikezwa nge-IV infusion, okusho ukuthi ulethwa ngqo emsingeni wakho ngomthambo. Le ndlela iqinisekisa ukuthi umuthi ufika ngempumelelo kumaseli omdlavuza emzimbeni wakho wonke. I-Daratumumab ingeyeqembu lemithi ebizwa ngokuthi ama-CD38-directed cytolytic antibodies, kodwa okubaluleke kakhulu ukuthi yakhelwe ukusebenza namasosha akho omzimba kunokuphikisana nawo.
I-Daratumumab ngokuyinhloko iphatha i-multiple myeloma, umdlavuza othinta amaseli e-plasma emnkantshubomvu wakho. Udokotela wakho angase ayinikeze yodwa noma ihlanganiswe neminye imithi yomdlavuza, kuye ngesimo sakho esithile.
Umuthi uvunyelwe izimo eziningana. Ungase uwuthole uma usanda kutholwa ukuthi une-multiple myeloma, uma umdlavuza wakho ubuyile ngemva kokwelashwa kwangaphambilini, noma uma ezinye izindlela zokwelapha zingasebenzanga njengoba bekulindelwe. Ngezinye izikhathi odokotela bayawusebenzisa i-light chain amyloidosis, isimo esihlobene lapho amaprotheni angavamile akha ezingxenyeni zakho zomzimba.
Iqembu lakho lezempilo lizothatha isinqumo sokuthi ngabe i-daratumumab ilungele yini wena ngokusekelwe ohlotsheni lomdlavuza onalo, impilo yakho iyonke, kanye nomlando wakho wokwelashwa. Uhambo lomdlavuza lomuntu ngamunye luhlukile, ngakho-ke uhlelo lwakho lokwelashwa luzoklanywa ngqo ngokuya ngezidingo zakho.
I-Daratumumab isebenza ngokugxila kuphrotheni ebizwa nge-CD38 ehlala ebusweni bamaseli e-multiple myeloma. Lapho umuthi unamathisela kule phrotheni, empeleni ubeka i-bullseye eselini lomdlavuza ukuze amasosha akho omzimba akwazi ukuliqaphela futhi alibhubhise.
Lokhu kuthathwa njengomuthi oqinile futhi osebenzayo emhlabeni wokwelashwa komdlavuza. Ngokungafani ne-chemotherapy yendabuko ethinta amaseli anempilo nawomdlavuza, i-daratumumab ikhetha kakhulu endleleni yayo. Igxila ikakhulukazi kumaseli anamazinga aphezulu e-CD38, okuhlanganisa iningi lamaseli e-myeloma.
Umuthi usebenza ngezindlela eziningi. Ungabulala ngokuqondile amaseli omdlavuza, uqashe amaseli omzimba ukuthi ahlasele amaseli omdlavuza amakwe, futhi uvimbele izindlela ezithile ezisetshenziswa amaseli omdlavuza ukuze asinde futhi akhule. Le ndlela enezinhlangothi eziningi iyenza isebenze ikakhulukazi ngamaseli omdlavuza aqinile.
I-Daratumumab inikezwa njalo njenge-intravenous infusion endaweni yokunakekelwa kwezempilo, hhayi ekhaya. Ithimba lakho lezempilo lizofaka ishubhu elincane emthanjeni engalweni yakho noma ngomugqa ophakathi uma unawo.
Ngaphambi kwe-infusion ngayinye, uzothola imithi yangaphambi kokwelashwa ukusiza ukuvimbela ukusabela komzimba. Lokhu kuvamile ukuhlanganisa ama-antihistamines, ama-corticosteroids, kanye nezinto ezinciphisa umkhuhlane. Ukuthatha le mithi cishe imizuzu engama-30 kuya ehora ngaphambi kwe-daratumumab infusion yakho kusiza umzimba wakho ukuthi ubhekane nokwelashwa ngokunethezeka okwengeziwe.
Ukufakwa komuthi ngokwawo kuthatha amahora amaningi, ikakhulukazi ngesikhathi sokwelashwa kwakho kokuqala. Ukufakwa kwakho kokuqala kungathatha amahora angu-6-8 ngoba ithimba lakho lizoqala umuthi kancane futhi likuqaphele ngokusondela. Ukufakwa okulandelayo kuvame ukuthatha amahora angu-3-4 njengoba umzimba wakho ujwayela ukwelashwa.
Akudingeki ukuthi udle noma yini ekhethekile ngaphambi kokwelashwa, kodwa ukuhlala unamanzi kahle kubalulekile. Letha ukudla okulula, ukuzijabulisa, nezingubo ezikhululekile ngoba uzohlala amahora amaningi. Izikhungo eziningi zokwelapha zinezihlalo ezincikayo nezinsiza zokukusiza ukuthi uhlale ukhululekile ngesikhathi senqubo.
Ubude bokwelashwa nge-daratumumab buhlukahluka kakhulu ngokuya ngesimo sakho esithile nokuthi usabela kanjani emuthini. Abanye abantu bayawuthola izinyanga eziningana, kanti abanye bangase bawudinge unyaka noma ngaphezulu.
Ekuqaleni, cishe uzothola ukufakwa kwamasonto onke ezinyangeni ezimbili zokuqala, bese kuba njalo njalo emavikini amabili ezinyangeni ezine ezilandelayo. Ngemuva kwalokho, abantu abaningi bashintshela ekufakweni kwanyanga zonke. Lolu hlelo luvumela umzimba wakho ukuthi ulungiswe ngenkathi ugcina amazinga okulwa nomdlavuza asebenzayo emuthini.
Udokotela wakho uzoqapha inqubekela phambili yakho ngokuhlolwa kwegazi okujwayelekile nokuskena okubonakalayo. Uma umdlavuza wakho usabela kahle futhi imiphumela emibi ihlala ilawuleka, ungaqhubeka nokwelashwa isikhathi eside. Umgomo uwukugcina umdlavuza wakho ulawulwa ngenkathi ugcina izinga lempilo yakho.
Ungayeki ukuthatha i-daratumumab ngaphandle kokuxoxa ngayo neqembu lakho lezempilo kuqala. Noma ngabe uzizwa ungcono, umuthi usengasebenza ukuze ugcine amaseli omdlavuza ekude. Udokotela wakho uzokusiza ukuthi uqonde ukuthi kufanelekile nini ukucabangela ukuyeka noma ukushintsha uhlelo lwakho lokwelashwa.
Njengazo zonke izidakamizwa zomdlavuza, i-daratumumab ingabangela imiphumela emibi, nakuba abantu abaningi beyibekezelela kahle. Imiphumela emibi evame kakhulu ivamise ukulawuleka ngokunakekelwa okufanele nokuqashwa okuvela eqenjini lakho lokunakekelwa kwezempilo.
Nansi imiphumela emibi ongase uyithole, futhi ukuyazi kungakusiza ukuthi uzizwe ulungiseleleke kakhulu:
Le miphumela emibi evamile ithinta abantu abaningi kodwa ivame ukuba mnene kuya kokulingene futhi ithuthuke ngokuhamba kwesikhathi. Ithimba lakho lokunakekelwa kwezempilo linolwazi lokuphatha lezi zimpawu futhi linganikeza amasu okukusiza ukuthi uzizwe ungcono.
Abanye abantu bathola ukusabela kokufakwa, okungenzeka ngesikhathi noma ngemva nje kokuthola umuthi. Lezi zimpawu zingase zihlanganise umkhuhlane, ama-chills, ubunzima bokuphefumula, noma ukuqubuka kwesikhumba. Imithi ozoyithola ngaphambi kokwelashwa ikusiza ukuvimbela lezi zimpawu, futhi ithimba lakho lokunakekelwa kwezempilo likuqapha eduze ngesikhathi sokufakwa ngakunye.
Imiphumela emibi engavamile kodwa ebucayi ingenzeka, nakuba ithinta abantu abambalwa. Lokhu kuhlanganisa izifo ezinzima ngenxa yokwehla komsebenzi wokuzivikela emzimbeni, ukwehla okukhulu kwamaseli egazi, noma izinkinga zesibindi. Udokotela wakho uzobheka lokhu ngokuqashwa okuvamile futhi angashintsha ukwelashwa kwakho uma kudingeka.
Imiphumela emibi engavamile ingabandakanya ukusabela okukhulu komzimba, izinkinga zenhliziyo, noma iminyango yesibili yomdlavuza, kodwa lokhu kwenzeka ngesilinganiso esincane sabantu. Nakuba kukhathaza, izinzuzo zokulawula umdlavuza wakho oyinhloko ngokuvamile zidlula lezi zingozi ezingavamile.
I-Daratumumab ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi iphephile yini kuwe. Abantu abanezifo ezinzima ezisebenzayo ngokuvamile kufanele balinde kuze kube yilapho ukutheleleka kuphela ngaphambi kokuqala ukwelashwa.
Uma unomlando wokungezwani komzimba okukhulu kuma-antibody e-monoclonal noma yiziphi izingxenye ze-daratumumab, udokotela wakho cishe uzoncoma ezinye izindlela zokwelapha. Labo abanezimo ezithile zenhliziyo noma izinkinga ezinzima zesibindi nabo bangase badinge ezinye izinketho zokwelapha.
Ukukhulelwa nokuncelisa ibele kuyizinto ezibalulekile okufanele zicatshangelwe. I-Daratumumab ingalimaza ingane engakazalwa, ngakho-ke abesifazane abangase bakhulelwe badinga ukulawulwa kokuzalwa okuphumelelayo ngesikhathi sokwelashwa kanye nezinyanga eziningana ngemva kwalokho. Uma uncelisa, uzodinga ukuyeka ngaphambi kokuqala i-daratumumab.
Abantu abanezifo ezithile zegazi noma labo abaye baba nokusabela okukhulu ekumpontshweni kwegazi bangase badinge izinyathelo zokuphepha ezikhethekile. Udokotela wakho uzobuyekeza umlando wakho wezokwelapha ophelele ukuze anqume ukuthi i-daratumumab iyisinqumo esifanele yini isimo sakho.
I-Daratumumab iyatholakala ngaphansi kwegama lomkhiqizo elithi Darzalex lokufakwa ngemithambo. Ungase futhi uzwe nge-Darzalex Faspro, okuyinguqulo engaphansi kwesikhumba efakwa ngaphansi kwesikhumba kunokuba nge-IV.
Zombili lezi zinhlobo ziqukethe isithako esifanayo esisebenzayo futhi zisebenza ngendlela efanayo, kodwa indlela yokulethwa iyahluka. Udokotela wakho uzokhetha ifomu elifanele kakhulu ngokusekelwe ezidingweni zakho ezithile, isimiso sokwelashwa, kanye nezintandokazi zakho.
Eminye imithi eminingi ingelapha i-multiple myeloma uma i-daratumumab ingakulungele. Lezi ezinye izindlela zisebenza ngezindlela ezihlukene kodwa zihlose ukufeza imigomo efanayo yokulawula umdlavuza wakho.
Ezinye izidakamizwa ze-monoclonal ezifana ne-elotuzumab noma i-isatuximab ziqondise amaprotheni ahlukene kumaseli omdlavuza. Imithi yamakhemikhali yendabuko, izidakamizwa ze-immunomodulatory ezifana ne-lenalidomide, noma izithiyo ze-proteasome ezifana ne-bortezomib zingase zibe izinketho kuye ngesimo sakho.
I-CAR-T cell therapy imelela enye indlela entsha lapho amaseli akho omzimba avuselelwa ukulwa nomdlavuza ngempumelelo. Ukufakelwa kwamaseli esiqu kungase kucatshangelwe kwabanye abantu, ikakhulukazi iziguli ezincane ezinempilo enhle.
Ithimba lakho lezempilo lizoxoxa nazo zonke izinketho ezifanele nawe, licabangela izici zomdlavuza wakho, impilo yakho yonke, ukwelashwa kwangaphambilini, nezintandokazi zakho. Ukwelashwa okungcono kakhulu kuvame ukuba yindlela yokuhlanganisa eyenzelwe ngqo izidingo zakho.
Ukuqhathanisa i-daratumumab ne-bortezomib akulula ngoba zisebenza ngendlela ehlukile futhi zivame ukusetshenziswa ndawonye kunokuba zibe ezinye izindlela eziqhudelanayo. Zombili ziyimithi yomdlavuza esebenzayo, kodwa ziqondise izici ezihlukene ze-multiple myeloma.
I-Bortezomib iyisithiyo se-proteasome esiphazamisa indlela amaseli omdlavuza acubungula ngayo amaprotheni, kuyilapho i-daratumumab isebenzisa amasosha akho omzimba ukuhlasela amaseli omdlavuza ngokuqondile. Izinhlelo eziningi zokwelapha zihlanganisa zombili le mithi ngoba ziyagcwalisana.
Mayelana nemiphumela emibi, iyahluka kakhulu. I-Bortezomib ivame ukubangela i-peripheral neuropathy (ukulimala kwemizwa ezandleni nasezinyaweni), kuyilapho i-daratumumab ivame ukubangela ukukhathala nokusabela kokufakwa. Abanye abantu bayayibekezelela enye kangcono kunenye.
Ucwaningo lubonisa ukuthi ukuhlanganisa i-daratumumab nezindlela zokwelapha ezisekelwe ku-bortezomib ngokuvamile kuveza imiphumela engcono kunokusebenzisa i-bortezomib yodwa. Udokotela wakho uzocabangela izici zakho eziqondile zomdlavuza, ukwelashwa kwangaphambilini, kanye nempilo yakho yonke lapho enquma ukuthi iyiphi indlela engcono kakhulu kuwe.
I-Daratumumab ngokuvamile ingasetshenziswa ngokuphepha kubantu abanesifo sikashukela, kodwa ukuphathwa kukashukela wakho wegazi kubaluleke nakakhulu ngesikhathi sokwelashwa. Imithi ozoyithola ngaphambi kokwelashwa, ikakhulukazi ama-corticosteroids, ingakhuphula amazinga kashukela wegazi okwesikhashana.
Ithimba lakho lezempilo lizosebenza eduze nawe ukuze liqaphe ushukela wakho wegazi kaningi ngezinsuku zokwelashwa. Ungase udinge ukulungisa imithi yakho yesifo sikashukela noma imithamo ye-insulin okwesikhashana. Ukucindezeleka kokwelashwa komdlavuza kungase futhi kuthinte ushukela wegazi, ngakho-ke ukugcina ukulawula okuhle kwesifo sikashukela kusiza umzimba wakho ukuthi ubhekane nokwelashwa komdlavuza kangcono.
Awukwazi ukusebenzisa i-daratumumab eningi ngokungahlosiwe ngoba ngaso sonke isikhathi inikezwa ochwepheshe bezempilo endaweni yezokwelapha elawulwayo. Umuthi ubhalwa ngokucophelela ngokuya ngesisindo somzimba wakho futhi unikezwa kancane kancane nge-IV infusion.
Uma ukhathazekile ngokuthola umthamo ongalungile, unganqikazi ukubuza ithimba lakho lezempilo mayelana nokubalwa komthamo. Balandela izinqubo eziqinile ukuze baqinisekise ukuthi uthola inani eliqondile elibekwe udokotela wakho. Ukuphepha kwakho kuyinto eza kuqala kubo, futhi kunezinto eziningi ezenziwayo zokuvimbela amaphutha emithamo.
Uma uphuthelwa i-infusion ye-daratumumab ehleliwe, xhumana nethimba lakho lezempilo ngokushesha ukuze lihlehlise. Ungalindi kuze kube yilapho uqokwe khona okulandelayo ngoba ukugcina ukwelashwa okuqhubekayo kubalulekile ekulawuleni umdlavuza wakho.
Udktela wakho uzoqoka indlela engcono kakhulu yokubuyela emuva ohlelweni lwakho lokwelashwa. Ngezikhathi ezithile bangakwazi ukukuhlela kabusha phakathi nezinsuku ezimbalwa, kanti ngezinye izikhathi kungadingeka ukuthi balungise uhlelo lwakho lokwelashwa lonke. Okubalulekile ukuxhumana nethimba lakho ngokushesha ngangokunokwenzeka lapho kuvela izingxabano zokuhlela.
Isinqumo sokuyeka i-daratumumab sincike ezintweni eziningana udokotela wakho azohlola njalo. Ungayeka uma umdlavuza wakho ungena ekuxoleleni okuphelele, uma imiphumela emibi iba nzima kakhulu ukuphatha, noma uma umuthi uyeka ukusebenza ngempumelelo.
Udokotela wakho uzosebenzisa ukuhlolwa kwegazi, ukuskena kwezithombe, kanye nama-biopsy womnkantsha wamathambo ukuze ahlulele ukuthi ukwelashwa kusebenza kahle kangakanani. Abanye abantu bangayeka ngemva kokuzuza impendulo enhle futhi bahlale ekuxoleleni, kanti abanye badinga ukwelashwa isikhathi eside ukuze balondoloze ukulawulwa komdlavuza. Ungalokothi uyeke i-daratumumab ngokwakho ngaphandle kwesiqondiso sezokwelapha.
Imithi eminingi yokugoma ejwayelekile iphephile ngenkathi uthola i-daratumumab, kodwa imithi yokugoma ephilayo kufanele igwenywe ngoba ingabangela izifo kubantu abanezinhlelo zokuzivikela ezicindezelwe. Udokotela wakho cishe uzoncoma ukuhlala usesikhathini ngemijovo yomkhuhlane kanye neminye imigomo ebalulekile.
Umuthi wokugoma we-COVID-19 ngokuvamile unconywa kubantu abathola i-daratumumab, nakuba impendulo yakho yokuzivikela ingase yehliswe. Ithimba lakho lezempilo lizohlinzeka ngesiqondiso esithile mayelana nokuhlela imithi yokugoma ngesikhathi sokwelashwa kwakho kanye nokuthi yimiphi imithi yokugoma ebaluleke kakhulu esimweni sakho.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.